Se and Tepezza drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Se (selenium) and Tepezza (teprotumumab-trbw). Common drug interactions include muscle spasms among females and muscle spasms among males.

The phase IV clinical study analyzes what interactions people have when they take Se and Tepezza. It is created by eHealthMe based on reports of 62 people who take the same drugs from the FDA, and is updated regularly.

What is Se?

Se has active ingredients of selenium. eHealthMe is studying from 5,604 Se users. Check the latest studies of Se.

What is Tepezza?

Tepezza has active ingredients of teprotumumab-trbw. eHealthMe is studying from 3,632 Tepezza users. Check the latest studies of Tepezza.



On Jul, 15, 2026

62 people who take Se and Tepezza together, and have interactions are studied.

Se and Tepezza drug interactions.

What are the common drug interactions of Se and Tepezza, by gender? *:

female:

  1. Muscle spasms (muscle contraction)
  2. Pruritus (severe itching of the skin)
  3. Blood glucose increased
  4. Epistaxis (bleed from the nose)
  5. Headache (pain in head)
  6. Hypoacusis (loss of hearing)
  7. Nausea (feeling of having an urge to vomit)
  8. Fatigue (feeling of tiredness)
  9. Blood pressure increased
  10. Dizziness

male:

  1. Muscle spasms (muscle contraction)
  2. Abdominal pain upper
  3. Type 2 diabetes mellitus
  4. Vision blurred
  5. Ageusia (loss of taste functions of the tongue)
  6. Blood glucose increased
  7. Dysphonia (speech disorder attributable to a disorder of phonation)
  8. Fatigue (feeling of tiredness)
  9. Onychoclasis (breaking of the nails)
  10. Skin cancer

What are the common drug interactions of Se and Tepezza, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Glycosylated haemoglobin increased
  2. Amenorrhoea (absence of a menstrual period in a woman of reproductive age)
  3. Anaemia (lack of blood)
  4. Blood glucose increased
  5. Chest discomfort
  6. Deformity (disfigurement)
  7. Dizziness
  8. Dysphonia (speech disorder attributable to a disorder of phonation)
  9. Eye pain
  10. Eye swelling

40-49:

  1. Pruritus (severe itching of the skin)
  2. Alopecia (absence of hair from areas of the body)
  3. Blood pressure increased
  4. Dysgeusia (disorder of the sense of taste)
  5. Eustachian tube disorder (inflammation of the middle ear, commonly affects the eustachian tube)
  6. Hypoacusis (loss of hearing)
  7. Malaise (a feeling of general discomfort or uneasiness)
  8. Withdrawal syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance)

50-59:

  1. Muscle spasms (muscle contraction)
  2. Epistaxis (bleed from the nose)
  3. Nausea (feeling of having an urge to vomit)
  4. Abdominal pain upper
  5. Dry skin
  6. Ear discomfort
  7. Headache (pain in head)
  8. Onychoclasis (breaking of the nails)
  9. Pruritus (severe itching of the skin)
  10. Rash papular (redness with papule)

60+:

  1. Blood glucose increased
  2. Muscle spasms (muscle contraction)
  3. Dizziness
  4. Dry mouth
  5. Erythema (redness of the skin)
  6. Fatigue (feeling of tiredness)
  7. Food allergy
  8. Headache (pain in head)
  9. Hypersensitivity
  10. Hypoacusis (loss of hearing)

What are the existing conditions these people have? *

  1. Endocrine Ophthalmopathy (increased water content of retroocular orbital tissues; associated with thyroid disease, usually hyperthyroidism): 47 people, 75.81%
  2. Basedow's Disease (autoimmune disease where the thyroid is overactive, producing an excessive amount of thyroid hormones): 9 people, 14.52%

* Approximation only. Some reports may have incomplete information.

Do you take Se and Tepezza?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Se and Tepezza:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Se:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Tepezza:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Se and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tepezza and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on selenium and teprotumumab-trbw (the active ingredients of Se and Tepezza, respectively), and Se and Tepezza (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: